Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cellulitis
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Differential diagnosis=== Other conditions that may mimic cellulitis include [[Venous thrombosis|deep vein thrombosis]], which can be diagnosed with a compression leg [[medical ultrasonography|ultrasound]], and [[stasis dermatitis]], which is inflammation of the skin from poor blood flow. Signs of a more severe infection such as necrotizing fasciitis or [[gas gangrene]] that would require prompt surgical intervention include purple [[bulla (dermatology)|bulla]]e, skin sloughing, subcutaneous edema, and systemic toxicity.<ref name=":0" /> Misdiagnosis can occur in up to 30% of people with suspected lower-extremity cellulitis, leading to 50,000 to 130,000 unnecessary hospitalizations and $195 to $515 million in avoidable healthcare spending annually in the United States.<ref>{{Cite journal |last1=Weng |first1=Qing Yu |last2=Raff |first2=Adam B. |last3=Cohen |first3=Jeffrey M. |last4=Gunasekera |first4=Nicole |last5=Okhovat |first5=Jean-Phillip |last6=Vedak |first6=Priyanka |last7=Joyce |first7=Cara |last8=Kroshinsky |first8=Daniela |last9=Mostaghimi |first9=Arash |title=Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis |journal=JAMA Dermatology |volume=153 |issue=2 |pages=141β146 |doi=10.1001/jamadermatol.2016.3816 |pmid=27806170 |year=2017 |s2cid=205110504 |url=https://dash.harvard.edu/bitstream/1/33785925/1/jamadermatology_Weng_2016_oi_160057.pdf }}</ref> Evaluation by dermatologists for cases of suspected cellulitis has been shown to reduce misdiagnosis rates and improve patient outcomes.<ref name="pmid29453874">{{cite journal |vauthors = Li DG, Xia FD, Khosravi H, Dewan AK, Pallin DJ, Baugh CW | display-authors=etal |title=Outcomes of Early Dermatology Consultation for Inpatients Diagnosed With Cellulitis. |journal=JAMA Dermatol |year=2018 |volume=154 |issue=5 |pages=537β543 |pmid=29453874 |doi=10.1001/jamadermatol.2017.6197 |pmc=5876861}}</ref><ref name="pmid29453872">{{cite journal |vauthors = Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Shah R | display-authors=etal |title=Effect of Dermatology Consultation on Outcomes for Patients With Presumed Cellulitis: A Randomized Clinical Trial. |journal=JAMA Dermatol |year=2018 |volume=154 |issue=5 |pages=529β536 |pmid=29453872 |doi=10.1001/jamadermatol.2017.6196 |pmc=5876891}}</ref> Associated musculoskeletal findings are sometimes reported. When it occurs with [[acne conglobata]], [[hidradenitis suppurativa]], and [[pilonidal cyst]]s, the syndrome is referred to as the [[follicular occlusion triad]] or tetrad.<ref>{{cite journal |vauthors=Scheinfeld NS |title=A case of dissecting cellulitis and a review of the literature |journal=Dermatology Online Journal |volume=9 |issue=1 |pages=8 |date=February 2003 |doi=10.5070/D39D26366C |pmid=12639466 }}</ref> [[Lyme disease]] can be misdiagnosed as cellulitis. The characteristic [[Erythema chronicum migrans|bullseye rash]] does not always appear in Lyme disease (the rash may not have a central or ring-like clearing, or not appear at all).<ref name=wright_2012>{{cite journal |last1=Wright |first1=William F. |last2=Riedel |first2=David J. |last3=Talwani |first3=Rohit |last4=Gilliam |first4=Bruce L. |title=Diagnosis and management of Lyme disease |journal=American Family Physician |date=1 June 2012 |volume=85 |issue=11 |pages=1086β1093 |pmid=22962880 |url=https://www.aafp.org/link_out?pmid=22962880 }}</ref> Factors supportive of Lyme include recent outdoor activities where Lyme is common and rash at an unusual site for cellulitis, such as [[armpit]], [[groin]], or behind the knee.<ref name=CDC-Lyme-Data>{{cite web |title=Lyme Disease Data and surveillance |url=https://www.cdc.gov/lyme/datasurveillance/ |website=Lyme Disease |publisher=Centers for Disease Control and Prevention |access-date=April 12, 2019 |date=2019-02-05 |archive-date=2019-04-13 |archive-url=https://web.archive.org/web/20190413133319/https://www.cdc.gov/lyme/datasurveillance/ |url-status=live }}</ref><ref name=wright_2012/> Lyme can also result in long-term neurologic complications.<ref name=Aucott2015>{{cite journal |vauthors=Aucott JN |title=Posttreatment Lyme disease syndrome |journal=Infectious Disease Clinics of North America |volume=29 |issue=2 |pages=309β323 |date=June 2015 |pmid=25999226 |doi=10.1016/j.idc.2015.02.012}}</ref> The standard treatment for cellulitis, [[cephalexin]], is not useful in Lyme disease.<ref name=IDSALyme2006/> When it is unclear which one is present, the [[Infectious Diseases Society of America|IDSA]] recommends treatment with [[cefuroxime axetil]] or [[amoxicillin/clavulanic acid]], as these are effective against both infections.<ref name=IDSALyme2006/>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)